Clinical trials
Terminated Lung Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 2 |
| Novartis Pharmaceuticals | 2 |
| Turning Point Therapeutics, Inc. | 2 |
| Amgen | 1 |
| BeOne Medicines | 1 |
| Clinical Research Center for Solid Tumor, Korea | 1 |
| Elevation Oncology | 1 |
| Hanmi Pharmaceutical Company Limited | 1 |
| Hoffmann-La Roche | 1 |
| Korea University Guro Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 19 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Neoplasms | 6 |
| Neoplasm Metastasis | 4 |
| Adenocarcinoma | 3 |
| Adenocarcinoma of Lung | 3 |
| Carcinoma | 3 |
| Carcinoma, Bronchogenic | 3 |
| Head and Neck Neoplasms | 3 |
| Lung Diseases | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.